Gufic Biosciences Announces 42nd AGM on Sep 4, 2026, via VC/OAVM
Gufic Biosciences will hold its 42nd AGM on September 4, 2026, via VC/OAVM. A final dividend of ₹0.10 per share has been recommended, payable by October 3, 2026, to members on record as of August 28, 2026. Annual reports and AGM notices will be sent electronically.
The announcement pertains to standard corporate governance procedures (AGM) and a routine dividend declaration, which typically have a low immediate impact on the company's stock price or business operations.
The announcement is a routine corporate communication regarding the AGM and dividend, with no significant positive or negative financial or business developments.
Gufic Biosciences Limited has announced that its 42nd Annual General Meeting (AGM) will be held on Friday, September 04, 2026, at 3:30 p.m. IST. The meeting will be conducted through Video Conferencing (VC) / Other Audio Visual Means (OAVM), in compliance with the Companies Act, 2013, and SEBI Listing Regulations.
The Notice of the AGM and the Annual Report for the Financial Year 2025-26 will be sent electronically to members whose email addresses are registered by Friday, August 07, 2026. For members without registered email IDs, a web-link to access the Annual Report will be provided. These documents will also be available on the company's website (www.gufic.com) and the websites of BSE (www.bseindia.com) and NSE (www.nseindia.com), as well as NSDL (www.evoting.nsdl.com).
The company has also recommended a final dividend of ₹0.10 per equity share, subject to member approval. This dividend will be paid before October 03, 2026, to members whose names appear in the Register of Members as of Friday, August 28, 2026 (Record date), through online transfer modes. Members holding shares in physical form must ensure their PAN, contact details, and bank account details are updated with the RTA, MUFG lntime India Private Limited, or via email. For dematerialised shares, updates should be made with the respective Depository Participant.
Members will have the opportunity to cast their votes through remote e-voting prior to the AGM and e-voting during the AGM. The login credentials for e-voting can be used for attending the AGM. Detailed procedures for e-voting and attending the AGM are available in the AGM Notice and on the company and NSDL websites.
What to do with a filing like this
Gufic Biosciences Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gufic Biosciences Limited. Read the original for the full detail.